Alogliptin
As a gliptin, Alogliptin acts as an inhibitor of dipeptidyl peptidase 4. The substance is antidiabetic as it increases insulin secretion (exclusively in type 2 diabetes). It can be utilisedon its or as a combined preparation with metformin or pioglitazone.
Formula: C18H21N5O2
Molecular weight: 339.39 g/mol
Molecular size: Small
Controlled Substance: No
Precursor: No
Indications: Drugs used in diabetes
Status: Development
Axano Pharmaceuticals Ltd
- malta europe
- admin @axanopharmamalta.com
- [email protected]
- contact details
- Malta +356 27780827